ReviewFrontiers in immunology2024

The role and therapeutic targeting of the CCL2/CCR2 signaling axis in inflammatory and fibrotic diseases.

Shan Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.